A comparison of plasma polymorphonuclear leucocyte elastase levels in obese and lean individuals

Journal of International Medical Research

Volumn 26, Issue 5, 1998, Pages 252-256

  Adeyemi, E ^a   Benedict, S ^a   Abdulle, A ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cathepsin G; Elastase; Myeloperoxidase; Obesity; Polymorphonuclear leucocyte

Indexed keywords

ELASTASE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OBESITY; TISSUE INJURY;

EID: 0032414059     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059802600505     Document Type: Article

References (20)

1. Dowse GK, Zimmet PZ, Gareeboo H, et al: Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14: 271-282.
2. Larsson H, Ahren B: Islet cell dysfunction in obese women with impaired glucose tolerance. Metabolism 1996; 45:502-509.
3. Ohlsen L-O, Larsson B, Svardsudd K, et al: The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
4. Olefsky M, Kolterman OG, Scarlet JA: Insulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. Am J Physiol 1982; 243: E15-E30.
5. Vague J: The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Nutr 1956; 4: 20-34.
6. Plaisted CS, Istfan NW: Metabolic abnormalities of obesity. In: Obesity: Pathophysiology, Psychology and Treatment (Blackburn GL, Kanders BS, eds). New York: Chapman and Hall, 1994; pp 80-97.
7. Tanaka S, Inoue S, Isoda F, et al: Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes 1993; 17(11): 631-636.
8. Dattilo AM, Kris-Etherton PM: The effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 52: 320-328.
9. Stallone DD: The influence of obesity and its treatment on the immune system. Nutr Rev 1994; 52: 37-50.
10. Adeyemi EO, Chadwick VS, Hodgson HJF: The effect of some anti-inflammatory agents on elastase release from neutrophils in-vitro. J Pharm Pharmacol 1990; 42: 487-490.
11. Barrett AJ: Leucocyte elastase. Methods Enzymol 1981; 80: 581-588.
12. Baugh RJ, Travis J: Human leucocyte granule elastase: rapid isolation and characterization. Biochemistry 1976; 15: 836-841.
13. Treuhaft PS, McCarty DJ: Synovial pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 1971; 14: 475-484.
14. Velvart M, Fehr IC, Baici A, et al: Degradation in vivo of articular cartilage in rheumatoid arthritis by leucocyte elastase from polymorphonuclear leucocytes. Rheumatol Int 1981; 1: 121-130.
15. Declaration of Helsinki: Recommendations guiding medical doctors on biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and revised by the 29th World Medical Assembly, Tokyo , Japan, 1975.
16. WHO Expert Committee on Physical Status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva: World Health Organization, 1995; WHO Tech Report Series no. 854.
17. Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1977; 9: 24-34.
18. Trichieri G: Cytokines acting on or secreted by macrophages during intracellular infection (IL10, IL12, IFN-γ). Curr Opin Immunol 1997; 9: 17-23.
19. Boutten AMS, Dehoux N, Seta J, et al: Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996; 153: 336-342.
20. Barrett AJ: α-2-Macroglobulin. Methods Enzymol 1981; 80: 737-754.